HIGHLIGHTS OF UNION BUDGET 2026-27

1. At a Glance

• Union Budget 2026-27 presented by FM Nirmala Sitharaman on 1 February 2026 — her 8th consecutive budget and the first prepared at Kartavya Bhawan (replacing North Block) [1][2].
• Structured around 3 Kartavyas: (i) accelerating growth, (ii) building citizen capacity, (iii) Sabka Sath Sabka Vikas — anchored to the Viksit Bharat 2047 vision [1][5].
• Marks a continued fiscal consolidation glide path while sustaining record capex push for infrastructure and frontier manufacturing — high-yield for GS-III (Economy) prelims & mains [3][4].

2. Why in the News

• Tabled in Parliament on 1 Feb 2026; first budget housed in Kartavya Bhawan, the new Common Central Secretariat complex [1].
• Announces flagship Biopharma SHAKTI (₹10,000 cr / 5 yrs), SME Growth Fund (₹10,000 cr), AVGC Content Creator Labs in 15,000 schools, and 5 Regional Medical Hubs [1][3][5].
• Fiscal deficit target pegged at 4.3% of GDP (BE 2026-27), down from earlier years — signals continued post-FRBM consolidation [2].

3. Background & Evolution

• Budget cycle governed by Article 112 (Annual Financial Statement) of the Constitution; presented since 2017 on 1 February (advanced from end-February) [general constitutional context].
• Halwa ceremony marks start of printing; budget presented in paperless form since 2021 via Union Budget Mobile App [contextual].
• 2026-27 budget continues themes from 2024-25 ("Viksit Bharat") and 2025-26 (Saptarishi/4 engines), now reframed as 3 Kartavyas [1][5].
• Fiscal deficit trajectory: 5.6% (RE 2024-25) → 4.8% (RE 2025-26) → 4.3% (BE 2026-27) [2].

4. Core Static Facts

• Implementing body: Ministry of Finance; Department of Economic Affairs (Budget Division) [1].
• 6 growth-pillar interventions under First Kartavya: 7 strategic/frontier sectors manufacturing, legacy industries, Champion MSMEs, infrastructure, energy security, City Economic Regions [1].

5. Multi-Dimensional Analysis

Economic

• Capex multiplier sustained: ₹12.2 lk cr public capex (~3.6% of GDP) to crowd-in private investment [2][3].
• Debt-to-GDP slipping below 56% signals adherence to revised FRBM glide path announced in 2025-26 [2].
• STT raised on F&O (futures 0.02→0.05%; options premium 0.1→0.15%) — curbs derivative speculation flagged by SEBI [2].

Social

• ₹10,000 cr Biopharma SHAKTI + 3 new NIPERs + upgrade of 7 NIPERs target affordable biologics access [3].
• 5 Regional Medical Hubs positioned to scale medical tourism ("Heal in India") [1].
• AVGC Content Creator Labs in 15,000 secondary schools + 500 colleges via IICT Mumbai — skilling at scale [1].

Strategic / Industrial

• "7 strategic and frontier sectors" prioritised for manufacturing scale-up — extends PLI logic to deep-tech [1][3].
• Defence capex +17.6% YoY signals continued indigenisation under Atmanirbhar Bharat [3].

Administrative / Federalism

• City Economic Regions introduces a new sub-national planning unit beyond states — federalism implications [1].
• TCS rationalisation to 2% for alcoholic liquor/scrap/minerals & tendu leaves (5%→2%) — compliance ease for states' producers [2].

Agriculture

• Cooperative deduction extended to cotton seed & cattle feed suppliers; credit-linked subsidy for animal husbandry; Coconut Promotion Scheme [3].

6. Recent Developments (last 12-18 months)

• 1 Feb 2026: Budget 2026-27 tabled; first at Kartavya Bhawan [1].
• 31 Jan 2026: Economic Survey projected Real GDP growth 7.4% for FY 2025-26 [4].
• Feb 2026: Department of Pharmaceuticals released Biopharma SHAKTI strategy paper [3].
• 2025-26 Budget had introduced ₹12 lakh nil-tax threshold under new regime — carried forward [S6 contextual].

7. Prelims Hooks

• First Union Budget presented from Kartavya Bhawan — Budget 2026-27 [1].
• 3 Kartavyas = Growth + Capacity + Sabka Sath Sabka Vikas [1].
• Total expenditure BE 2026-27 = ₹53.5 lakh crore [2].
• Fiscal deficit BE 2026-27 = 4.3% of GDP [2].
• Public capex BE 2026-27 = ₹12.2 lakh crore [2].
• Biopharma SHAKTI outlay = ₹10,000 cr over 5 yrs; involves 3 new + 7 upgraded NIPERs and 1000+ accredited clinical trial sites [3].
• Defence capital outlay = ₹2.19 lakh crore (+17.6%) [3].
• MoHFW allocation = ₹1,06,530.42 crore [3].
• STT on futures raised from 0.02% → 0.05% [2].
• TCS on tendu leaves cut from 5% → 2% [2].
• AVGC labs: IICT Mumbai to assist setup in 15,000 schools + 500 colleges [1].
• Debt-to-GDP BE 2026-27 = 55.6% [2].
• Six intervention areas under First Kartavya; 7 strategic & frontier sectors identified for manufacturing scale-up [1].
• 5 Regional Medical Hubs for medical tourism [1].
• SME Growth Fund = ₹10,000 crore [3].

8. Mains Relevance

• GS-III: Indian Economy — Government Budgeting; Mobilisation of Resources; Infrastructure; Industrial policy.
• GS-II: Government schemes (Biopharma SHAKTI, AVGC labs); Centre-State relations (City Economic Regions).
• Likely question stems: 1. "Critically examine the sustainability of India's capex-led growth strategy in light of Budget 2026-27." 2. "The introduction of 'City Economic Regions' marks a shift in India's urban-economic planning. Discuss." 3. "How does Budget 2026-27 align fiscal consolidation with the Viksit Bharat 2047 vision?"

9. Related Topics to Study Next

• FRBM Act, 2003 — fiscal deficit glide path context.
• Article 112 / 110 / 117 — constitutional budget framework.
• Economic Survey 2025-26 — GDP 7.4% projection [4].
• PLI Scheme & 7 frontier sectors — manufacturing linkage.
• 15th/16th Finance Commission — federal devolution backdrop.
• NIPERs & Department of Pharmaceuticals — Biopharma SHAKTI delivery [3].
• SEBI F&O regulation — context for STT hike [2].
• AVGC-XR National Policy 2024 — basis of AVGC labs.

10. Common Errors / Trap Areas

• 3 Kartavyas ≠ Saptarishi (2023) ≠ 4 Engines (2025) — each budget has its own framing; do not conflate.
• Biopharma SHAKTI is under Department of Pharmaceuticals (Min. of Chemicals & Fertilizers), not DBT or MoHFW [3].
• Fiscal deficit 4.3% is BE 2026-27; the RE 2025-26 figure (4.8%) is often confused.
• Kartavya Bhawan (new CCS building) ≠ North Block; first budget prepared there in 2026 [1].
• Capex ₹12.2 lk cr is Centre's capex; gross Centre+State capex is higher — don't equate.
• STT changes apply to F&O; cash market STT unchanged [2].